Medtronic authorizes an incremental $5B for share repurchases

The board authorized the expenditure of funds for share repurchases. Given the remaining amount under the board’s March 2019 $6B authorization was $1.9B by the end of the last fiscal quarter, the board today authorized an incremental $5B for share repurchases. The company noted that there is no specific time period associated with this repurchase authorization.